The extracellular factors that determine a cell's responsiveness to neurotransmitters are of particular relevance for pharmacologically diverse cell types such as neurons and smooth muscle. We previously demonstrated that matrix-associated factors are capable of dramatically and specifically suppressing the responsiveness of smooth muscle to the neuropeptide, substance P. We now demonstrate that this influence of extracellular matrix on the pharmacological phenotype of smooth muscle cells can be blocked specifically by an Arg-Gly-Asp (RGD)-containing antagonist of integrins. Of a battery of integrin ligands tested, only thrombospondin mimicked the effect of the extracellular matrix on substance P responsiveness. This effect of thrombospondin was dose dependent, RGD sensitive, and blocked by an antibody directed against the RGD-containing region of thrombospondin. Because the mRNA for thrombospondin is present in the cells of the chicken amnion, this extracellular factor may normally suppress substance P responsiveness in amniotic smooth muscle. The results suggest a role for matrix-associated integrin ligands in the regulation of cellular responses to specific neurotransmitters and hormones and in the development and maintenance of tissue-specific pharmacological properties.
The ability of the extracellular matrix (ECM) to influence the phenotype of a variety of cell types is well established (1) . Important effects of ECM include simple changes in cell shape (e.g., adhesion and spreading in vitro), migration, proliferation, differentiative morphogenesis, and subcellular localization of neurotransmitter receptors. Certain effects of ECM appear to result from cellular interaction with abundant, generic components of the matrix [e.g., laminin (2) (3) (4) ], whereas other effects are due to more specialized factors of limited distribution that are associated with the matrix [e.g., agrin (5) ]. Many interactions of a cell with its immediate environment are mediated by ECM-specific receptors on the cell surface. A particularly well-characterized family of such receptors is the integrins, originally described as binding the Arg-Gly-Asp (RGD)-containing domains of their ligands (6) ; it is now clear that many integrins also bind ligands in an RGD-independent fashion (7) . Other types of receptors are also involved in cell-matrix interaction, including proteoglycans located in the plasma membrane (5, 8) . The ECM is in a unique position with regard to the regulation of cellular phenotype due to its molecular complexity, its ability to bind and concentrate otherwise soluble factors, and its direct proximity to cells.
For certain cell types, such as smooth muscle and neurons, responsiveness to different neurotransmitters is an important aspect of their phenotype. The regulation of pharmacological phenotype includes decisions concerning the types and subtypes of receptors expressed, their coupling to intracellular
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events, and when and where to place these receptors on the cell surface. Work from both neurons and muscle suggests that extracellular factors play important instructive roles in the process of receptor regulation. For example, nonneuronal cells from sensory ganglia powerfully suppress nicotinic receptor expression in dissociated sensory neurons (9) , and extracellular factors, associated with ECM, direct the aggregation of cholinergic receptors at the neuromuscular junction (5) .
To identify molecules normally influencing the pharmacological phenotype of smooth muscle, this laboratory has recently characterized a regulatory interaction between avian amniotic ECM and amniotic smooth muscle cells. The avian amnion is an anatomically simple system, consisting only of an epithelium and a layer of avascular, uninnervated smooth muscle. We have previously demonstrated that amniotic ECM specifically suppresses the responsiveness of amniotic smooth muscle cells to the peptidergic neurotransmitter, substance P (10). These results suggested that components of ECM may determine the dramatic variations in pharmacological properties observed between tissues in vivo. For example, bladder and iris smooth muscle from the rabbit contract in response to nanomolar substance P, whereas the smooth muscle from rabbit aorta is unresponsive (11) (12) (13) (14) . We now report that the influence of the ECM on substance P responsiveness in smooth muscle cells is mediated by an RGD-dependent process, suggesting the involvement of integrins. Substrates. Glass coverslips were coated with 0.25 mg/ml poly(DL-ornithine) as described (10) Isolation of Amniotic Basement Membrane. Sheets of amniotic basement membrane were isolated free of muscle nuclei and cellular debris as described (10), with minor modifications. In the present context, the term "basement membrane" denotes an extracellular structure distinct from "basal lamina"; the distinguishing characteristic of basement membrane is the presence of fibrillar collagen. After hypotonic lysis of the smooth muscle and removal of the epithelium, the crude basement membrane was pressed onto a polyornithine-coated coverslip, smooth muscle side up, in sterile distilled water containing a cocktail of protease inhibitors (phenylmethylsulfonyl fluoride at 100 ,tg/ml, leupeptin at 0.32 ,tg/ml, and pepstatin at 0.32 ,ug/ml). The extracellular membrane was then treated with DNase and deoxycholate and thoroughly rinsed as described (10) . Basement membranes were rinsed with medium and allowed to equilibrate in N2 for 1-2 hr prior to culturing smooth muscle cells on them.
Assay of Contractile Responses to Neurotransmitters. Responses to different neurotransmitter-related substances were monitored visually at x400 with Hoffman optics during superfusion with Hepes-buffered physiological saline at 33°C, as described (10) . Transmitters were applied via pressure ejection from micropipettes with a tip diameter of [3] [4] [5] [6] ,lm. The H2 blocker cimetidine (3 ,uM) was present continuously during contractility assays. Visual determination of whether a cell contracted in response to drug application was unambiguous and occurred within 1 sec of agonist application (10, 15). (10) . Protein and RNA synthesis inhibitors completely block this induction of substance P responsiveness without decreasing cholinergic responsiveness (Fig.  1) .
The induction of substance P responsiveness in dissociated smooth muscle cells is prevented by plating the cells onto isolated basement membrane from amnion, indicating the presence of a suppressive factor in amniotic ECM (10) . This suppression of substance P responsiveness by amniotic ECM is blocked by the integrin antagonist Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) (Fig. 2) . The control peptide, Gly-Arg-Gly-GluSer-Pro (GRGESP), has no effect. These data suggest that an integrin ligand in the amniotic ECM is suppressing substance P responsiveness in amniotic smooth muscle. Neither hexapeptide affected carbachol responses (Fig. 2) Table 1 ). The only ECM molecule that specifically inhibited contraction in response to substance P was hTSP1.
Most of the substrates examined in the present report had obvious qualitative effects on cell shape, adherence, or proliferation, indicating that active molecules had been applied as substrates. For example, fewer smooth muscle cells adhered to tenascin and collagen V, resulting in a much lowered population density and more rounded cells. Cells plated onto Matrigel, vitronectin, fibronectin, or collagen IV flattened and proliferated. The concentration of laminin used for the smooth muscle cells was sufficient to cause extensive neurite outgrowth from cultured sympathetic neurons (data not shown).
TSP Mimics the Basement Membrane Effect. hTSPI inhibited the substance P response of the smooth muscle cells in a dose-dependent manner and was maximally active at 25 gg/ml (Fig. 3) . This dose range is the same as that reported for 1 . Induction of the substance P response is blocked by both protein and RNA synthesis inhibitors. The percentages of cells contracting in response to 100 ,.M carbachol or 100 nM substance P were assessed after 1 day in culture on polyornithine in the presence or absence of different RNA or protein synthesis inhibitors. The induction of substance P responsiveness is completely blocked by cycloheximide (10 j,g/ml; protein synthesis inhibitor), 40 ,uM DRB (RNA synthesis inhibitor), or a-amanitine (2 ,ug/ml; RNA synthesis inhibitor). Ctrl, control. Note that the carbachol response is unaffected by these treatments. carbachol or 100 nM substance P were assessed after 2 days in culture on polyornithine (P-ORN) or basement membrane (BMb) with or without the hexapeptide GRGDSP or GRGESP at 100 ,Lg/ml. Substance P responses on both polyornithine and basement membrane plus RGD are significantly different from those on basement membrane alone (P < 0.001, ANOVA; mean + SEM, n = 6). The homologous RGE peptide has no significant influence on the basement membrane effect (n = 2).
maximal coating of a culture surface by TSP (24) and for maximal cell adhesion to TSP (25). Even at the highest concentrations, hTSP1 had no effect on the cells' responsiveness to either carbachol or histamine (Fig. 4) . Complete inhibition of substance P responsiveness lasted for at least 6 days in culture, the longest time point examined using TSP (data not shown). The degree of block by hTSP1 was identical to that observed with isolated basement membrane; the percentages of cells responding to substance P after 48 hr were 21 + 2 versus 21 + 3 on TSP (n = 14) or basement membrane (n = 12), respectively. As seen with the basement membrane (Fig.  2) , the RGD peptide blocked the hTSP1-mediated inhibition of substance P responsiveness without affecting the cells' response to either carbachol or histamine (Fig. 4) antibody, R5, generated against the RGD-containing type 3 repeat region of recombinant hTSP1 (23). Purified R5 IgG blocked the hTSP1 effect, while IgG from nonimmune serum did not (Fig. 5) , demonstrating that the activity of the TSP preparations is due to TSP rather than a copurified contaminant. The ability of R5 antiserum to inhibit the effects of avian amniotic basement membrane was examined also, and no effect was observed (percentage of cells responding to substance P on basement membrane vs. basement membrane plus R5 was 4% vs. 10%, respectively). As the R5 antiserum was generated against hTSP1, and the homologous molecule in avian amnion is probably cTSP2 (see next section and Discussion), a lack of cross-reactivity of R5 to the active avian molecule is not surprising. Consistent with this, R5 antiserum detected no high molecular weight bands in Western blots of chicken serum or chicken amnion extract (data not shown).
mRNA for cTSP2 Is Present in Avian Amnion. Although several different genes for TSP have been cloned in mammalian systems (26, 27), only one form has been described in chicken (22) . The cloned cTSP is most homologous to mouse and hTSP2, despite the fact that probes to TSP1 were used for ,uM carbachol and 100 nM substance P were assessed after 2 days in culture. Anti-TSP antibody (R5) and nonimmune IgG (IgG) were present in culture medium at 250 jig/ml. Values for substance P responsiveness in the presence of hTSP and hTSP plus IgG are both different from all other values (P < 0.001). P-ORN, polyornithine.
its isolation. This form of TSP therefore will be referred to as cTSP2. Using RNA isolated from whole amnion and nested primers, reverse transcriptase-PCR generated only the expected 339-bp fragment, with no band generated when transcriptase was omitted (Fig. 6) . The amplified region corresponds to a region of cTSP2 that is near the carboxyl terminus, a region unique to the TSPs (26, 28). Association of this 339-bp fragment with cTSP2 was further strengthened by restriction digestion with Bgl I, producing the expected 98-and 241-bp fragments (Fig. 6) . Sequencing of the first 150 bases of the cloned fragment, including the Bgl I site, verified its identity with the expected region of cTSP2 [100% identity with the published sequence in Lawler et al. (22)]. Contamination by genomic sequences is effectively ruled out, because (i) no amplified product was evident in the absence of reverse transcriptase (Fig. 6 ) and (ii) analysis of the genomic organization of TSP1 and TSP2 indicates no exons larger than 300 bp in this region of the gene (22, 29-31). These data, therefore, demonstrate the presence of the mRNA for cTSP2 in the chicken amnion. stance P responsiveness and is mediated via an RGD-sensitive receptor. The percentages of cells contracting in response to 100 ,uM carbachol, 100 ,uM histamine, and 100 nM substance P were assessed after 2 days in culture. The RGD and RGE peptides were both used at 100 ,ug/ml. Values for substance P responsiveness in the presence of hTSP and hTSP plus RGE are both different from all other values (P < 0.001). P-ORN, polyornithine. (6, 7, 32) . These results suggest specific influences of integrins and their ligands on the pharmacological phenotype of smooth muscle cells, expanding the possible roles of these receptors beyond adhesion-based assays or more global differentiating instructions (e.g., proliferation and morphology).
The lack of effect of TSP on the responses of amniotic smooth muscle to carbachol and histamine is noteworthy. The carbachol response is mediated by a muscarinic receptor (10, 17) and is so reliably observed in this system that it serves as an indication of the general viability and contractility of the smooth muscle (17). The histamine response in this system is mediated by the Hi receptor, while the substance P response appears to be mediated by the neurokinin 1 receptor (10) . Generally, the Hi and neurokinin 1 responses share appreciable second messenger mechanisms as both activate the inositol phospholipid pathway via pertussis toxin-insensitive G proteins in many tissues (see ref. 33 for further references). Although these intracellular mechanisms have not been verified in amniotic muscle, the specificity of TSP for substance P responses indicates that it is not altering mechanisms shared by histamine. Given the specificity, the sensitivity to synthesis inhibitors, and the time course of the effect, the simplest hypothesis is that an induction of substance P receptor synthesis mediates the appearance of substance P responsiveness in culture. However, increased neurokinin 1 expression has not yet been documented. (47) .
The homology between hTSP1 and cTSP2 varies as a function of the region of the molecule that is analyzed. About 34% homology exists in the heparin-binding amino-terminal region of the two molecules, while about 80% homology is observed in the RGD-containing and carboxyl-terminus region of the molecule (22). A mimicry of the effects of the RGD region of cTSP2 by hTSP1 is, therefore, consistent with the regional homology of these two molecules. A parsimonious and testable hypothesis is that a TSP, bound in the ECM, normally suppresses the substance P responsiveness of amniotic smooth muscle via an integrin. Blocking antisera against the RGD domain of the cTSP2, as well as antibodies to other domains, will be particularly useful in rigorously testing this hypothesis.
The possibility that TSP may influence the regulation of substance P responsiveness in other pharmacologically versatile cells like vascular smooth muscle and neurons needs examination, as this molecule is synthesized and secreted by vascular endothelial cells (48) (49) (50) and is widespread in brain (51, 52) . In addition to an influence on substance P responsiveness, an examination of the influence of TSP(s) on expression of the neuropeptide, substance P, is of interest, because ECM-associated components are in an ideal position to interact with both pre-and postsynaptic cells. Thus, there may be a role for ECM in coordinating the expression of transmitters and their receptors.
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